BUILDING A NEW RESEARCH AND DEVELOPMENT LABORATORY OF QUINTA – ANALYTICA S.R.O. is co-financed by the European Union.

 

The aim of the project is to build a new research and development laboratory in Brno, which will significantly lead to the expansion of the existing research and innovation capacity (VIK). The project will create a top workplace equipped with the latest instruments and equipment for the analysis of medicinal products.

Project Name: Rozšíření výzkumné a vývojové kapacity společnosti QUINTA-ANALYTICA, s.r.o.

Project Number: CZ.01.1.02/0.0/0.0/20_338/0023928

EUROPEAN UNION

European Regional Development Fund

OP Enterprise and Innovation for Competitiveness

Additional News

  • 22 června 2023

    Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies

    EvidentIQ partners with Quinta-Analytica to enhance Phase 1 study efficiency

  • 15 června 2023

    Novavax & Conscio: Behind the Scenes of Vaccine Development

    Discover how the Conscio Group and renowned vaccine manufacturer Novavax collaborate behind the scenes to ensure quality and efficiency in vaccine production.

  • 8 června 2023

    Clinical Tips – Drug Interactions in Advanced Clinical Trial Design

    Drug interactions play a key role in the design of clinical trials. Learn how we investigate such interactions when conducting pharmacokinetic/bioequivalence studies and while offering end-to-end support throughout the process.